Filing Details
- Accession Number:
- 0001209191-10-022995
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-04-20 13:00:00
- Reporting Period:
- 2010-04-16
- Filing Date:
- 2010-04-20
- Accepted Time:
- 2010-04-20 15:56:42
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
917520 | Integra Lifesciences Holdings Corp | IART | Laboratory Analytical Instruments (3826) | 510317849 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1187572 | Iii B John Henneman | 311 C Enterprise Drive Plainsboro NJ 08536 | Evp, Finance & Admin & Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2010-04-16 | 7,500 | $38.72 | 97,248 | No | 4 | M | Direct | |
Common Stock | Disposition | 2010-04-16 | 7,500 | $45.03 | 89,748 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2010-04-16 | 7,500 | $0.00 | 7,500 | $38.72 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2011-02-01 | No | 4 | M | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
- The price shown above represents the weighted average price of the shares sold. The range of sale prices was $45.00 to $45.24.
- 25% of the shares have vested on the first anniversary of the grant date of 02/01/2005 and the remaining 75% vested monthly thereafter over 36 months.